|
|
Miscellaneous Rheumatic and Inflammatory Diseases
Session Type: ACR Concurrent Abstract Sessions
Monday, October 19, 2009: 4:30 PM-6:00 PM
203 B (Pennsylvania Convention Center)
| Organizer: |
John A. Goldman, MD, Medical Quarters
|
| Moderators: |
Christopher R. Morris, MD, Arthritis Associates
and
Kristine M. Lohr, MD, MS, University of Kentucky
|
Papers:
4:30 PM
Is Infliximab Effective and Safe for the Treatment of Refractory Non Infectious Inflammatory Uveitis?. A Systematic Literature Review
Ana M. Ortiz, M.D., PhD, Hospital Universitario de la Princesa;
Estibaliz Loza, MD, Fundación Española de Reumatología;
Miguel Abad, Hospital Virgen del Puerto;
Felix Francisco, Hospital Doctor Negrin;
Jesús Maese, M, M.D., Fundación Española de Reumatología;
Santiago Muñoz-Fernández, Hospital Infanta Sofía;
Loreto Carmona, MD, PhD, Fundación Española de Reumatología;
Esperanza Pato, Hospital Clínico San Carlos
4:45 PM
Cardiac Sarcoidosis: Clinical, Diagnostic, Therapeutic and Outcome Features From a Series of 126 Patients
Damien Sène, MD, Department of Internal Medicine, Pitié-Salpêtrière Hospital;
Catherine Chapelon-Abric, MD, Department of Internal Medicine, Pitié-Salpêtrière Hospital;
David Saadoun, MD, Department of Internal Medicine, Pitié-Salpêtrière Hospital;
Alexis Mathian, MD, Department of Internal Medicine, Pitié-Salpêtrière Hospital;
Nathalie Costedoat-Chalumeau, MD, Department of Internal Medicine, Pitié-Salpêtrière Hospital;
Julien Haroche, M.D., PhD, Department of Internal Medicine, Pitié-Salpêtrière Hospital;
Du Li Thi Huong-Boutin, MD, Department of Internal Medicine, Pitié-Salpêtrière Hospital;
Jean -Charles Piette, MD, Department of Internal Medicine, Pitié-Salpêtrière Hospital;
Patrice P. Cacoub, MD, Department of Internal Medicine, Pitié-Salpêtrière Hospital;
Zahir Amoura, M.D., Department of Internal Medicine, Pitié-Salpêtrière Hospital
5:15 PM
Efficacy and Safety of Canakinumab (Ilaris) in A Large Cohort of Patients Across Different Severity Phenotypes of Cryopyrin Associated Periodic Syndrome (CAPS)
J.B. Kuemmerle-Deschner, Universitätsklinikum Tübingen, Klinik fuer Kinder-und Jugendmedizin;
H.J. Lachmann, Royal Free and University College Medical School;
E. Hachulla, Hopital Claude Huriez;
J. Hoyer, Univ.-Klinikum Gießen und Marburg;
J. Smith, University of Wisconsin Hospital and Clinics;
K. Leslie, UCSF, School of Medicine;
I. Kone-Paut, Hopital Kremlin Bicetre;
J. Braun, Rheumazentrum Ruhrgebiet;
A. Widmer, Novartis;
N. Patel, Novartis;
R. Preiss, Novartis;
P.N. Hawkins, Royal Free and University College Medical School
5:30 PM
Familial Mediterranean Fever (FMF)-Associated B30.2 (PRYSPRY) Mutations Activate a NLRP3-Independent Inflammasome and Induce Autoinflammatory Disease in Mice
Jae Jin Chae, PhD, Inflammatory Biology Section, Laboratory of Clinical Investigation, NIAMS, NIH;
Young-Hun Cho, MD, Dermatology Branch, NCI, NIH;
Jun Cheng, PhD, Genetics and Molecular Biology Branch, NHGRI, NIH;
Maria Mosaico, PhD, Laboratory Animal Sciences Program, SAIC-Frederick, NCI, NIH;
P. Paul Liu, PhD, Genetics and Molecular Biology Branch, NHGRI, NIH;
Lionel Feigenbaum, PhD, Laboratory Animal Sciences Program, SAIC-Frederick, NCI, NIH;
Stephen I. Katz, MD, PhD, Dermatology Branch, NCI, NIH;
Daniel L. Kastner, MD, PhD, Inflammatory Biology Section, Laboratory of Clinical Investigation, NIAMS, NIH
5:45 PM
Rilonacept: Long-Term Safety Profile in Patients with Cryopyrin-Associated Periodic Syndromes (CAPS)
Hal M. Hoffman, M.D., University of California at San Diego;
Douglas R. Nadler, Regeneron Pharmaceuticals, Inc.;
Warren P. Brooks, PhD, Regeneron Pharmaceuticals, Inc.;
Steven P. Weinstein, MD, PhD, Regeneron Pharmaceuticals, Inc.
|
![[Visit Client Website]](/img/acr/banner_2009.gif)
Search
Print Page
Browse by Day: 
